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Abstract 
Background 
Premenstrual syndrome (PMS) is a combination of physical, psychological and emotional symptoms 
that occur periodically before menstruation and disappear with the onset of menstruation. There are 
some therapeutic methods mostly according to the clinical trials that reduce the prevalence and 
intensity of symptoms of PMS by unknown mechanisms. This study aimed to investigate the effects 
of Calcium and vitamin B1 on Premenstrual syndrome among female students. 
Materials and Methods: This is a triple-blind clinical trial conducted on 210 female students living in 
dormitories of Ilam University of Medical Sciences who had PMS. PMS symptoms questionnaire was 
used to investigate the symptoms. Participants were assigned in 3 groups of 70 people with the 
following regimen: group 1 received one pill containing 100 milligrams vitamin B1, group 2 received 
Calcium pills and group 3 received placebo. The participants in all groups took medicines for 2 
months and then reported the intensity of their symptoms by the questionnaire. The collected data was 
analyzed by descriptive and inferential statistics, using SPSS-16. 
Results: In groups receiving vitamin B1, Calcium and placebo, the intensity of physical and 
psychological symptoms as well as general symptoms of PMS had a remarkable reduction (P<0.05). 
However, comparison between intervention and control groups showed that the reduction in intensity 
of symptoms in groups receiving supplements (vitamin B1 and Calcium) (P<0.05). Vitamin B1 and 
Calcium had equal effects on improvement of physical symptoms of PMS, but Calcium reduced 
psychological symptoms better than vitamin B1. 
Conclusion: Results of this study showed that both vitamin B1 and Calcium reduce physical 
symptoms of premenstrual syndrome, but in terms of reducing psychological symptoms Calcium was 
more effective.  
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1- INTRODUCTION 
Premenstrual syndrome (PMS) is one of 
the most prevalent disorders during 
reproductive age which is seen regularly in 
most of menstrual cycles  and is related to 
luteal phase of menstruation period (1, 2). 
This disorder encompasses a group of 
physical and psychological changes that 
happen 7 to 14 days prior to menstruation 
and will disappear with initiation of 
menstruation. In some cases the intensity 
of symptoms is such that interferes with 
personal works, every day activities, social 
activities and family relationships (3- 5). 
The prevalence of PMS has been between 
10 to 90 percent in different studies and 
the main reason of this wide range is the 
difference in definitions, diagnostic criteria 
and demographical characteristics (6-8). 
Some factors like age, menstruation 
characteristic, socioeconomic status, 
education level, consumption of hormonal 
medicines and life style including diet and 
physical activity may affect PMS (6, 9). 
Patients with PMS have reported about 
150 physical and psychological symptoms 
including abdominal discomfort, headache, 
backache, edema, weight gaining, breast 
tenderness, bloating, increased appetite, 
palpitation, restlessness, increased stress, 
change in sleeping habits, moodiness, 
isolation and withdrawal, change in 
everyday activities, absenteeism, lack of 
concentration, crying, depression, 
irritability, aggression and so on (10-12). 
This disorder may also lead to more 
serious problems like marital relationship 
disruption, mother- child relationship 
problems, social isolation, reduced 
attention, increase in psycho-somatic 
diseases complains and even criminal 
behaviors and tend to suicide (13-14). This 
issue not only leads to anxiety and reduced 
quality of life for women, it has a negative 
effect on economic indices directly via 
increased treatment costs and indirectly via 
absenteeism and reduced productivity at 
work; therefore, it is necessary to treat 
PMS (15). Because of uncertainty about 
pathophysiology of this syndrome, many 
treatment protocols and more than 300 
treatments have been recommended to 
relieve symptoms of this syndrome (16). 
The treatment recommendations include: 
treatment with drug (like taking anti-
depression and anti-anxiety drugs),  taking 
oral supplements (like Bromocriptine, 
vitamins, Calcium, Magnesium), 
consumption of natural products ( like 
herbal extracts and oils such as primrose 
oil), changing the life style (like having 
exercise and diet and so on) and behavior 
therapy (15). The main goal of PMS 
treatment is controlling symptoms such 
that patient has a proper function during all 
levels of menstruation (14). 
Vitamin B1 (Thiamin) is one of the oral 
supplements used to treat PMS. This 
vitamin my reduce symptoms of PMS via 
coenzyme function in metabolism of 
carbohydrates, lipids, proteins and the 
main amino acids that have a role in 
incidence of physical and psychological 
symptoms of PMS (17). In this study, 
vitamin B1 was in form of pills containing 
100 milligram vitamin B1 which was taken 
twice a day.  
Another oral supplement used to treat PMS 
is Calcium. According to the studies 
Calcium may affect the physical and 
psychological aspects of PMS (18). 
Changes in the cellular Calcium 
concentration may have some stimulating 
effect on neuromuscular connections, 
irritability, fatigue, anxiety, behavioral 
changes, depression and muscular cramps 
(19, 20). In this study Calcium supplement 
was in form of pills containing 500 
milligram Calcium carbonate.  
Many studies have been conducted on 
PMS treatment. In the recent studies more 
attention has been paid to new therapeutic 
methods that are according to clinical trials 
and through some unknown mechanisms 
lead to the reduction in prevalence and 
severity of disturbing symptoms of PMS. 
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Prescription of Calcium and various 
regimens of vitamin B are also among 
those treatment methods (21). A few 
studies in Iran have shown the effect of 
each treatment on reducing PMS 
symptoms. However these studies have not 
exactly determined the amount of their 
effectiveness and also they have not shown 
the best therapeutic method. Considering 
the importance of PMS and low cost of its 
treatment with supplements, this study 
aimed to compare the effect of Calcium 
and vitamin B1 on PMS in female students 
in Ilam city, Iran (Figure.1).  
 
Fig.1: Location of Ilam city, Iran 
2- MATERIALS AND METHODS 
2-1. Study design and Population 
This is a triple-blinded clinical trial 
conducted on female students living in 
dormitories of Ilam University of Medical 
Sciences, Iran.  
According to the similar studies (23, 24) 
and by using the following formula, and 
also considering the 95% confidence 
interval(CI), 80% test power, x 1 = 12.2, 
SD1= 24.1,  x 2= 1.6 and SD2= 16.6, the 
sample size was calculated to be 216 
people. 
n = ( 1 /2Z  + 1Z  ) (
2
1 +
2
2 ) / ( 1 - 2
2)    
where, σ1+σ2 is the difference of variance 
between two study populations, Z: is the 
normal distribution, β the chance of type 
two errors, α: the chance of type one error 
and µ1-µ2 the mean difference between 
two study populations. 
At the beginning of the study, 400 students 
completed the PMS questionnaire that 234 
of them had moderate to severe PMS 
symptoms. 24 students withdrew the study 
and ultimately 210 students were studied. 
Participants were randomly assigned in to 
3 groups of 70 people including: group 1 
receiving tablets containing 100 
milligrams vitamin B1 (made in 
Shimidaroo Company, Tehran, Iran), 
group 2 receiving tablets containing 500 
milligrams Calcium (made in Shimidaroo 
Company, Tehran, Iran) and group 3 
receiving placebo.  
It must be mentioned that the placebo was 
a tablet containing 1 gram starch. 
Participants did not know in which group 
they are. Personnel also did not know 
anything about people in each group and 
just giving the drugs which were packed in 
similar packages to the participants. 
The first group took a pill containing 500 
milligrams of Calcium carbonate once a 
day, the second group 100 milligrams of 
vitamin B1 once a day and the third group 
a placebo containing 1 milligram of starch 
once a day.  
The distribution of supplements and 
monitoring its consumption was done by 
trusted personnel and the main executors 
of the plan by visiting dormitories 
regularly once a week. According to the 
formula, the sample size was 216. At the 
beginning of the study 400 questionnaires 
were distributed among students and 234 
people were diagnosed by PMS. 
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2-2. Measuring tools 
The PMS symptoms questionnaire was 
given to the qualified people. The 
questionnaire was derived from Bakhshaee 
et al.’s study (22) and contained 2 parts. 
The first part included the demographical 
questions such as age, field of education 
and marital status and the second part 
included 21 self-reporting questions which 
were assessing the frequency and severity 
of PMS symptoms, 10 questions about 
psychological symptoms and 11 questions 
about physical symptoms of PMS. Items of 
these questionnaire, is derived from DMS-
IV diagnostic criteria for pre-menstruation 
dysphoric disorder and PMS symptoms 
and is known as a reliable questionnaire. 
Students were asked to mark their signs 
and symptoms during last 2 menstruation 
cycles and by this way having PMS was 
proven. In contrast, those who had at least 
5 symptoms of PMS with the intensity of 
moderate and more, form 7 days before to 
4 days after menstruation and during last 
two menstruation cycles were diagnosed as 
a person with PMS (those who had 
reported slight symptoms were not 
considered with PMS). 
Participants were asked to take a pill per 
day from 7 days before to 4 days after the 
menstruation for two menstruation cycles  و
and then mark the intensity of their 
symptoms in the questionnaire. At the end 
of the study questionnaires were collected 
and the mean of the intensity of symptoms 
was calculated. The mean intensity of 
symptoms was calculated by adding the 
intensity of symptoms from 7 days before 
to 4 days after menstruation and dividing 
that to the number of days. The minimum 
score was 0 and the maximum was 57.  
The scoring was according to the intensity 
of symptoms felt by participants, such that  
not to feel  any symptom was scored zero, 
slight symptoms 1, moderate symptoms 2, 
relatively high symptoms  3 and intensive 
symptoms was scored 4. The Cronbach's 
alpha coefficient for the questionnaire was 
calculated to be 0.8. In order to determine 
the reliability and also content and face 
validity  of the questionnaire, 11 copies of 
that was given to 11 specialists in 
nutrition, midwifery and gynecology to 
verify the  content. Overall each 
participant took 22 pills during the study 
and they were asked to consume them in 
one hour after a meal. 
2-3. Inclusion Criteria  
Inclusion criteria were: age of 18-30 years 
old, because normally students at 
Universities are in this range of age, 
having normal body mass index (BMI), 
having regular menstruation every 24-35 
days, having PMS symptoms in the second 
half of the menstruation period and having 
PMS symptoms in three consecutive 
cycles.  
Lactating mothers, patients with physical 
and mental diseases, people taking 
sedative drugs, hormonal drugs and 
contraceptives continuously, consumers of 
vitamins, antiepileptic drugs and 
antidepressant drugs during last 3 months 
were excluded. Some other exclusion 
criteria were having especial diets, having 
cervical and urinary diseases, and having 
menstruation cycles of less than 24 more 
than 35 days, smoking and having too 
much stress during last 3 months. 
2-4. Ethical considerations  
This study has been approved by ethical 
committee of Ilam University of Medical 
Sciences on 9
th
 December 2015 and 
obtained the permission with the reference 
number of "ir.medilam.rec.1394.88". The 
proposal is registered at the international 
center of Iranian trials with the reference 
number of IRCT2016011810333N3.  
All the information about participants is 
available with the researcher and the study 
results have been published without 
mentioning the patients’ names. All of the 
tests and services have been offered free of 
charge and patients have paid nothing. 
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After explaining the objectives of the 
study, written consent was obtained from 
all participants. 
2-5. Data analyses 
The collected data was analyzed by SPSS-
16 software. Descriptive   statistics were   
performed   to   discover    means ± 
standard   deviation   (SD)   for   incessant 
variables and percentage (%) for definite   
variables, correspondingly. Kolmogorov-
Smirnov test, independent and paired T-
test and ANOVA was implemented. The 
significance level was set at 0.05. 
3- RESULTS 
24 out of 234 students who had 
moderate to severe symptoms of PMS, 
withdrew the study and 210 students were 
studied. They were assigned into 3 groups 
of 70 people and received vitamin B1, 
Calcium and placebo respectively.  
24 people of the participants did not 
continue the study due to various reasons 
like not to follow the drug consumption 
order, forget to take drugs and not to 
complete the questionnaire and therefore 
information of 186 students was analyzed 
(Figure.2). 
The mean age of participants was 20.32 ± 
8.92 years, the mean body mass index  
22.1± 8.92 that falls in the range of normal 
BMI which is 19.8 to 24.8, the mean 
menstruation cycle 28.41 ± 3.04 days and 
the mean menstruation days was 6.38 ± 
3.05 days. Most of the participants 
(89.53%) were single. 
The mean intensity of physical, 
psychological and general PMS symptoms 
before the initiation of the study in 3 
groups of placebo, Calcium and vitamin 
B1 is illustrated in Table.1.  
As it is shown, the intensity of symptoms 
in all groups has been almost equal and 
results of comparing the intensity of PMS 
symptoms by statistical tests also show 
that before intervention, there has been no 
statistically significant difference between 
groups    (P> 0.05). The effect of 
intervention on intensity of PMS 
symptoms in groups receiving vitamin B1, 
Calcium and placebo is shown in Table.2. 
The mean intensity of physical, 
psychological and general PMS symptoms 
in each group before and after intervention 
was compared.  
The results showed a statistically 
significant difference between groups 
(P<0.001). In other words, after 
intervention, the intensity of physical, 
psychological and general PMS symptoms 
had a remarkable reduction in all groups 
(Table.2).  
As it is shown in Table.2, vitamin B1 has 
reduced the intensity of physical, 
psychological and general PMS symptoms 
more than placebo and this reduction is 
statistically significant (P<0.001).  
Table.4 shows the comparison between 
the mean intensity of PMS symptoms 
between groups of Calcium and placebo 
after intervention. In this case also the 
difference was statistically significant 
(P<0.001). In other words, taking Calcium 
has reduced the physical, psychological 
and general symptoms of PMS much more 
than placebo. 
Results of this study show that the 
reduction of physical symptoms of PMS in 
groups receiving vitamin B1 and Calcium 
is almost equal.  
Therefore we may say that these two 
supplements have the same effect on 
improvement of physical symptoms of 
PMS but Calcium reduces the 
psychological symptoms more than 
vitamin B1.  
Overall, calcium is more effective on 
reduction of general symptoms of PMS but 
these results are not statistically significant 
(P> 0.05). 
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  Table-1: Demographic characteristics of children in control (n=40) and interventional (n=40) groups 
Variables 
Interventional Group Control Group P- value 
N (%) or Mean(SD) N (%) or Mean(SD) 
Gender  
0.501 Male 20 (46.5%) 23 (53.4%) 
Female 20 (54%) 17 (46%) 
Age  
 
0.249 
3 years 18 (64.2%) 10 (35.8%) 
4 years 9 (37.5%) 15 (62.5%) 
5 years 8 (50%) 8 (50%) 
6 years 5 (41.6%) 7 (58.4%) 
Weight 14.40±1.676 14.02±1.625 0.313 
Time of venipuncture 4.92+1.071 4.70+0.966 0.327 
 
  Table 2: Comparison the pain mean during the intervention in control and interventional groups 
Pain Mean (SD)    Independent t-test         P- value 
Control group 
 
7.95 (1.084) 
 
17.505 
 
0.001 
Interventional group 2.65 (1.577) 
 
Table 3: Comparison the categorical pain intensity during the intervention in control and interventional groups  
Pain Intensity Control group 
N (%) 
Interventional group 
N (%) 
P- value 
Low (0-3) 0 31 (77.5%)  
0.001 Average  (4-7) 11 (30%) 9 (22.5%) 
High (8-10) 29 (70%) 0 
 
4- DISCUSSION 
Pre-menstruation syndrome is one of 
the most common disorders among women 
in reproduction age and is one of the most 
prevalent causes of their referring to the 
clinics which is seen in 85 to 90% of them 
with different degrees (14, 17). Until now 
there has been no unanimously accepted 
therapeutic method to improve PMS 
symptoms. Therefore we decided to 
investigate the effect of two common 
supplements (Calcium and vitamin B1) in 
reducing PMS symptoms. 
The difference between the mean general 
intensity of symptoms before and after 
intervention showed that both Calcium and 
vitamin B1 significantly reduce the overall 
intensity of PMS symptoms more than 
placebo (P<0.001). However, the amount 
of reduction of the intensity of PMS 
symptoms in the group receiving Calcium 
was more. This result is consistent with the  
 
results of other studies conducted on the 
effectiveness of Calcium. In a study 
conducted by Thys-Jacobs et al. on 441 
women with PMS, daily consumption of 
calcium carbonate had a significant effect 
on reduction of intensity of the PMS 
symptoms in comparison with placebo 
(48% vs. 30%) (18). In another study 
conducted by Akhlaghi et al. on 100 
students living in the dormitory, after 
treatment with Calcium, 62% reduction in 
psychological symptoms and 61% 
reduction in physical symptoms was 
reported (25). Studies conducted by 
Bertone-Johnson and Bebdich also 
reported the positive effect of Calcium 
supplements on reduction of PMS 
symptoms (26, 27). 
As it was mentioned, results of this study 
indicate the effect of Calcium on the 
reduction of physical and psychological 
Samieipour et al. 
Int J Pediatr, Vol.4, N.9, Serial No.33, Sep 2016                                                                                               3525 
symptoms of PMS. However, the mean 
intensity reduction of PMS psychological 
symptoms in the group receiving Calcium 
was more than the other groups. Therefore 
we may say that calcium consumption has 
had more effect on the reduction of 
psychological symptoms of PMS. This 
result is consistent with the results of other 
studies. Ghanbari et al. showed that the 
amount of reduction in psychological 
symptoms of PMS including fatigue, 
negative changes and depression among 
women receiving Calcium was 
significantly more than those who had 
received placebo (P<0.002) (20). The 
research conducted by Thys-Jacobs et al. 
showed that Calcium is effective to control 
psychological symptoms of PMS. They 
reported 45% reduction in depression 
among women receiving Calcium versus 
28% in the group receiving placebo (28). 
In another study, Penland and Johnson 
found out that Calcium consumption 
remarkably reduces problems of 
concentration, fatigue and behavioral 
changes related to psychological 
symptoms of PMS (P=0.01) (29).  
The positive effect of Calcium in reduction 
of PMS related behavioral disorders has 
been reported in another study (P=0.045) 
(30). It has been claimed that changes in 
Calcium concentration inside and outside 
cells may has stimulating effects on 
neuromuscular junctions and incidence of 
psychological symptoms of PMS (19, 20). 
Overall, results of these studies show that 
treatment by Calcium supplements is a 
beneficial method to reduce psychological 
symptoms of PMS. As no side effect and 
allergic reaction has been reported in 
previous studies, in this study also no side 
effect related to taking this medicine was 
observed. Results of this study indicate the 
positive effect of vitamin B1 on treatment 
of PMS symptoms as well and this result is 
consistent with the result of other studies. 
Results of Abdollahi et al.’s study showed 
that consumption of vitamin B1 
significantly reduces the physical and 
psychological symptoms of PMS (17). The 
mean reduction in the intensity of 
symptoms was 25.09 ± 0.73 which is more 
than the result observed in the present 
study. May be its because of taking two 
pills per day and continue of interventions 
for 3 menstruation cycles in their study 
while in this study participants took one 
pill per day for 2 months. In another study 
on the effect of vitamin B1, Zafari and 
Aghamohammadi found out that taking 
this medicine has been beneficial to treat 
physical and psychological symptoms of 
Dysmenorrhea (33). Gabriel et al. also 
showed that vitamin B1 consumption can 
reduce all symptoms of PMS (34).  
In some other studies it was proven that 
absorption of vitamin B1 from food 
sources, is related to the remarkable 
reduction in PMS symptoms (35, 36). It 
has been proven that vitamin B1 leads to 
the promotion of women’s quality of life 
via coenzyme formation during 
metabolism of carbohydrates, lipids, 
proteins and amino acids and therefore 
reduction in physical and psychological 
symptoms of PMS like fatigue, depression, 
stress, anger, sleeping disorders, reduced 
muscular cramps and pain and release of 
energy (37-39).  
In this study, no side effect related to 
consumption of this medicine was 
observed. According to the studies 
conducted on treatment of PMS symptoms 
with supplements, many confounding 
factors may affect the results. These 
factors include age, education level, 
economic status, living place and stress. 
We tried to minimize the effect of these 
factors by conducting a triple-blind 
random study on students living in 
dormitory who were similar in terms of 
age, education level and living place. By 
excluding the students taking daily 
nutritional supplements, we tried to 
perform a standard intervention in which 
all participants have the same situation. 
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However, they were different in the 
intensity of PMS symptoms and need to be 
treated and perhaps this has affected the 
results. Strengths and limitations of this 
study were mentioned above. 
4-1. Limitations of the study 
    Lack of motivation among students and 
problems in convincing them about 
benefits of participating in this study.  
5. CONCLUSION 
This study showed that both studied 
supplements (Calcium and vitamin B1) 
have positive and significant effects on 
improvement of physical, psychological 
and general symptoms of PMS. The effect 
of treatment with Calcium on reducing 
PMS symptoms especially on 
psychological symptoms was more than 
vitamin B1. No adverse effect was 
observed in those took these two 
supplements. Therefore it is recommended 
to consume both supplements especially 
Calcium to treat PMS. 
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